Arş. Gör. Dr. Abdulmunir AZİZY

Yayın Ağı

Makaleler 14

1. Prognostic Significance of Nomogram and T-Score in Locally Advanced Cervical Cancer Patients Treated with Curative Chemoradiotherapy and Image-Guided Brachytherapy: A Single-Center Retrospective Study

İBİŞ K., ILGIN C., Suncak L., Akbas C. K., BÖLÜKBAŞ D., DENİZLİ M., et al.

Diagnostics , cilt.15, sa.17, 2025 (SCI-Expanded, Scopus)

2. Clinical factors predicting objective response to bevacizumab-based chemotherapies in advanced and recurrent epithelial ovarian cancer

Khanmammadov N., Dogan I., Okay N. S., KHISHIGSUREN B., AZİZY A., Saip P., et al.

Minerva obstetrics and gynecology , cilt.77, sa.2, ss.112-118, 2025 (ESCI)

3. Rechallenge of trastuzumab-based therapy in HER2-positive breast cancer patients who progressed after lapatinib plus capecitabine

Khanmammadov N., Doǧan I., KHISHIGSUREN B., AZİZY A., Saip P., AYDINER A.

Medicine (United States) , cilt.104, sa.6, 2025 (SCI-Expanded)

4. Comparison of efficacy and safety of 5-FU or capecitabine combined with cisplatin and docetaxel (mDCF and mDCX) as a first-line chemotherapy regimen in her 2-negative metastatic gastric cancer patients: A retrospective study

DEMİRCİ N. S., AZİZY A., Paksoy N., Doǧan I., KARABULUT S., Karahan L., et al.

Medicine (United States) , cilt.103, sa.9, 2024 (SCI-Expanded) Sürdürülebilir Kalkınma

5. Comparative analysis of doublet chemotherapy regimens plus bevacizumab in patients with recurrent ovarian cancer

Khanmammadov N., Doǧan I., Okay N. S., AZİZY A., Saip P., AYDINER A.

Medicine (United States) , cilt.103, sa.1, 2024 (SCI-Expanded) Sürdürülebilir Kalkınma

6. Evaluation of the Efficacy of Bevacizumab-based Therapies in Patients with Platinum-Resistant or-Allergic Metastatic Ovarian Cancer

Khanmammadov N., Doğan İ., Okay N. S., YILDIZ A., Khishigsuren B., AZİZY A., et al.

Turk Onkoloji Dergisi , cilt.39, sa.2, ss.176-182, 2024 (ESCI) Sürdürülebilir Kalkınma

7. Efficacy of Intrathecal Therapy In Breast Cancer Patients With Leptomeningeal Metastasis

Khanmammadov N., Dogan I., AHMED M. A., YILDIZ A., Nizam N., KHISHIGSUREN B., et al.

Eastern Journal of Medicine , cilt.29, sa.4, ss.503-508, 2024 (Scopus)

8. The safety and efficacy of first-line atezolizumab plus bevacizumab in patients with unresectable hepatocellular carcinoma: A multicenter real-world study from Turkey

Akyildiz A., Guven D. C., Ozluk A. A., Ismayilov R., Mutlu E., Unal O. U., et al.

Medicine , cilt.102, sa.45, 2023 (SCI-Expanded) Sürdürülebilir Kalkınma

9. Efficacy of Capecitabine and Temozolomide Regimen in Neuroendocrine Tumors: Data From the Turkish Oncology Group

Ünal Ç., AZİZY A., KARABULUT S., TAŞTEKİN D., AKYILDIZ A., YAŞAR S., et al.

The oncologist , cilt.28, sa.10, ss.875-884, 2023 (SCI-Expanded)

10. Do Not Forget Afghanistan in Times of COVID-19: Telemedicine and the Internet of Things to Strengthen Planetary Health Systems

Azizy A., Fayaz M., AĞIRBAŞLI M. A.

OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY , cilt.24, sa.6, ss.311-313, 2020 (SCI-Expanded)

11. Immunohisto chemical expression of plasminogen activator inhibitor-1 in subcutaneous versus omental adipose tissue in patients after elective abdominal surgery

Yildiz M., BOZKURTLAR E., Azizy A., Agirbasli M.

Autopsy and Case Reports , cilt.9, sa.4, 2019 (Scopus)

12. Free estradiol index levels associated with high sensitivity CRP levels in male children

AĞIRBAŞLI M. A., Tanrikulu A., Azizy M.

TURKISH JOURNAL OF PEDIATRICS , cilt.59, sa.1, ss.49-55, 2017 (SCI-Expanded)

13. Total cholesterol-to-high-density lipoprotein cholesterol ratio predicts high-sensitivity C-reactive protein levels in Turkish children

AĞIRBAŞLI M. A., Tanrikulu A., Sevim B. A., Azizy M., BEKİROĞLU G. N.

JOURNAL OF CLINICAL LIPIDOLOGY , cilt.9, sa.2, ss.195-200, 2015 (SCI-Expanded) Sürdürülebilir Kalkınma

14. Serum paraoxonase-1 activity in children: the effects of obesity and insulin resistance

AĞIRBAŞLI M. A., Tanrikulu A., Erkus E., Azizy M., Acar Sevim B., Kaya Z., et al.

ACTA CARDIOLOGICA , cilt.69, sa.6, ss.679-685, 2014 (SCI-Expanded)

Kitaplar 1

1. Gastroenterologic Manifestations of Hematologic Diseases: Is it Common or Rare?

Azizy A., Çetiner M.

Gastrointestinal Involvement of Systemic Diseases, Profesör Doktor ŞAFAK KIZILTAŞ, Editör, Türkiye Klinikleri Yayınevi, İstanbul, ss.8-11, 2021 Sürdürülebilir Kalkınma

Yayınlar & Eserler